bovilis logo with green cow replacing 'o'

The new look of protection.

All cattle vaccines from Merck Animal Health now live under the BOVILIS name. They’re the same vaccines you’ve relied on for years – only with updated names and packaging. Each product has its own distinct color and is clearly marked, making it easy to ensure you’re selecting the right vaccine at the right time.

Give calves the most comprehensive BRD vaccine.

BOVILIS VISTA ONCE SQ is the only injectable cattle vaccine that demonstrates efficacy against five viral causes (IBR, PI3, BRSV, BVD Type 1 and 2) and two bacterial causes of respiratory disease (Pasteurella multocida and Mannheimia haemolytica).

BOVILIS VISTA ONCE SQ is shown effective against Pasteurella multocida and is now labeled for BVD Type 1b.1 No other injectable respiratory vaccine does more.

The first and only intranasal vaccine proven effective against viral and bacterial pneumonia.

It’s shown effective against IBR, BRSV, Pl3, Pasteurella multocida and Mannheimia haemolytica. BOVILIS NASALGEN 3-PMH is also safe to use in calves 1 week of age or older for a strong, healthy foundation. And a unique BluShadow® diluent means there’s no second-guessing which animals have been vaccinated.

Gain More with BOVILIS VISION.

BOVILIS VISION vaccines are shown effective against clostridial disease. Each is powered by the proprietary SPUR adjuvant that boosts vaccine performance while causing fewer reactions and reducing stress on cattle post-vaccination.2-4 This also leads to better feed conversion and increased weaning weights when compared to conventional clostridial vaccines.5-8

Stop pinkeye before it starts.

For broad coverage, choose a combination approach to vaccination. 

BOVILLIS® PILIGUARD® vaccines and BOVILIS® 20/20 VISION® 7 are shown effective against Moraxella bovis, a major cause of pinkeye. However, a recent study found up to 80% of cases include Moraxella bovoculi alone or along with M. bovis.9 Utilizing Morazella Bovoculi Bacterin to protect against M. bovoculi, along with your other pinkeye solutions, can help ensure maximum coverage.

Groundbreaking vaccinations

Innovation is critical in vaccine development. Merck Animal Health has a history of finding a better way forward through game-changing advancements, and today offers one of the most complete vaccine portfolios.

Learn from members of the teams who brought these vaccines to market.

BOVILIS® NASALGEN®:
Intranasal Vaccine Technology

BOVILIS® VISION®:
Low-Stress Clostridial Vaccines

BOVILIS® VISTA®:
Addressing Emerging Diseases

From the ranch to the feedyard, preconditioning improves performance.
With the right PrimeVAC program, you can give your cattle the marketing edge they need so you get the payday you deserve.

Learn about the different programs below. Then talk to your Merck Animal Health representative to get started.

No items to show.

Loading…

See more available vaccine options in the BOVILIS portfolio from Merck Animal Health.

Browse the complete BOVILIS vaccine lineup below.

Respiratory

Respiratory diseases are the most common and costly infections plaguing the North American cattle industry.10,11
Cattle vaccines from Merck Animal Health are designed to protect your herd and profits.

Shown to be effective for the vaccination of healthy cattle, 1 week of age or older against infectious bovine rhinotracheitis (IBR) virus, bovine respiratory syncytial virus (BRSV), parainfluenza 3 virus (PI3), Mannheimia haemolytica and Pasteurella multocida

Shown to be effective for the vaccination of healthy cattle, 1 week of age or older against infectious bovine rhinotracheitis (IBR) virus, bovine respiratory syncytial virus (BRSV) and parainfluenza 3 virus (PI3).

Shown effective for the vaccination of healthy cattle 5 months of age or older against infectious bovine rhinotracheitis (IBR) and parainfluenza 3 (PI3) viruses.

Shown effective for the vaccination of healthy cattle 3 months of age or older against respiratory disease due to Mannheimia haemolytica and Pasteurella multocida.

Shown to be effective for the vaccination of healthy cattle 1 week of age or older against disease due to Mannheimia haemolytica and Pasteurella multocida.

Shown effective for the vaccination of healthy cattle 3 months of age or older against respiratory disease and abortion due to infectious bovine rhinotracheitis (IBR), respiratory disease and fetal infection, including persistently infected calves due to bovine virus diarrhea virus (BVD) Types 1 and 2, bovine respiratory syncytial virus (BRSV) and parainfluenza3 virus (PI3).

Shown to be effective for the vaccination of healthy cattle, 3 months of age or older against respiratory disease and fetal infection, including persistently infected calves due to bovine virus diarrhea virus (BVD) Types 1 and 2.

Shown to be effective for the vaccination of healthy cattle 3 months of age or older against respiratory disease and abortion due to infectious bovine rhinotracheitis (IBR), respiratory disease and fetal infection, including persistently infected calves due to bovine virus diarrhea virus (BVD) Types 1 and 2, bovine respiratory syncytial virus (BRSV), parainfluenza3 virus (PI3), Mannheimia Haemolytica and Pasteurella multocida.

Clostridial (Black Leg)

Naturally found in soil and the intestines of cattle, clostridial organisms can cause unexpected mortality to a herd in the form of blackleg and other fatal diseases. Protect your herd’s health and your profits with vaccines from Merck Animal Health.

Shown to be effective for the vaccination of healthy cattle and sheep against disease caused by Clostridium chauvoei, Cl. Septicum, Cl. novyi, Cl. sordellii, Cl. perfringens Types C and D.

Shown to be effective for the vaccination of healthy cattle against disease caused by Clostridium chauvoei, Cl. septicum, Cl. novyi, Cl. sordellii, Cl. perfringens Types C and D, and Histophilus somni.

Shown to be effective for the vaccination of healthy cattle and sheep against Clostridium chauvoei, C. septicum, C. haemolyticum, C. novyi, C. sordellii, C. perfringens Type C and D.

Shown to be effective for the vaccination of healthy cattle against disease caused by Clostridium chauvoei, Cl. septicum, Cl. haemolyticum, Cl. novyi, Cl. sordellii, Cl. perfringens Type C and D, and Histophilus somni.

Show to be effective for the vaccination of healthy cattle, sheep and goats against Enterotoxemia caused by Clostridium perfringens Types C & D.

Shown to be effective for the vaccination of healthy cattle, sheep and goats against disease caused by Clostridium perfringens Types C and D and Cl. tetani.

Shown to be effective for the vaccination of healthy cattle 3 months of age or older against disease caused by Clostridium chauvoei, Cl. septicum, Cl. novyi Type B, Cl. haemolyticum, Cl. sordellii, Cl. tetani and Cl. perfringens Types C and D.

Shown to be effective for the vaccination of healthy cattle and sheep against disease caused by Clostridium chauvoei, C. septicum, C. novyi Type B, C. haemolyticum (known also as C. novyi Type D), C. tetani and C. perfringens Types C and D.

Reproductive

Breeding stock and their offspring are critical to the success of your operation. Protect both with the reproductive lineup of vaccines from Merck Animal Health.

Shown to be effective for the vaccination of healthy cattle 6 months of age or older against L. canicola, L. grippotyphosa, L. hardjo including L. borgpetersenii serovar hardjo bovis, L. icterohaemorrhagiae, and L. pomona. Effective against urinary shedding of L. hardjo bovis organisms.

Shown effective for the vaccination of healthy cattle 6 months of age or older against respiratory disease and abortion due to infectious bovine rhinotracheitis (IBR), respiratory disease and fetal infection, including persistently infected calves due to bovine virus diarrhea virus (BVD) Types 1 & 2, bovine respiratory syncytial virus (BRSV), parainfluenza3 virus (PI3) and leptospirosis. 

Shown to be effective for the vaccination of healthy cattle 3 months of age or older against respiratory disease and abortion due to infectious bovine rhinotracheitis (IBR), respiratory disease and fetal infection, including persistently infected calves due to bovine virus diarrhea virus (BVD) Types 1 and 2, bovine respiratory syncytial virus (BRSV), parainfluenza3 virus (PI3), Mannheimia Haemolytica and Pasteurella multocida.

Shown effective for the vaccination of healthy cattle 6 months of age or older against reproductive disease caused by Campylobacter fetus and leptospirosis.

Mastitis

Your cows’ production and your operation’s profitability take a direct hit if coliform mastitis takes hold. Vaccinate before it impacts your milk string.

Shown to be effective for vaccination of healthy adult cattle, including pregnant cattle, against mastitis due to Escherichia coli.

Scours

Calf scours – neonatal diarrhea – exerts a costly toll on the livestock industry. While the bacteria, viruses and parasites that cause the disease are a part of livestock production, scours can be prevented. For exceptional protection, turn to vaccines from Merck Animal Health.

Shown to be effective for the vaccination of healthy pregnant cattle to provide passive immunity against neonatal calf diarrhea due to bovine Group A Serotype rotaviruses, enterotoxigenic E. coli pilus type K99, and bovine coronavirus, and enterotoxemia due to C. perfringens Types C & D in calves.

Intranasal vaccine shown to be effective for the vaccination of healthy calves against enteric disease caused by bovine coronavirus. Efficacy shown in calves 3 days of age and older. Safety has been shown in calves 1 day of age and older.

Pinkeye

Spread by flies, pinkeye causes pain, stress and weight loss in cattle. If your cattle go blind or develop clouded eyes, your operation’s profitability will take an additional hit. Prevent pinkeye before it blindsides your ROI.

Shown to be effective for the vaccination of healthy cattle against disease caused by Clostridium chauvoei, Cl. septicum, Cl.novyi, Cl. sordellii and Cl. perfringens Types C and D and Moraxella bovis.

Shown effective for the vaccination of healthy cattle against Moraxella bovis.

See more high-quality products and solutions that can help you run your dairy as efficiently as possible.

herd of healthy cows in field

No matter the need, Merck Animal Health has the right BRD solution for the situation.

Red Angus Cattle Group

Get the latest updates! Sign up to receive cattle health management insights, industry news and more sent straight to your inbox.

References

1. Based on product labels
2. FTR 92-3 Vision 8 Injection Site Blemish Study.
3. FTR 96-2 Analysis of Post-Vaccinal Injection Sites Using Ultrasound.
4. FTR 96-4 Evaluation of Injection Site Blemishes Using Ultrasonography Following Administration of Two Commercial Multivalent Clostridial Vaccines.
5. Technical Services Field Trial Report 93-9. 1993. Weaning weight comparison of Vision 7 and Ultrabac 7 in a Wyoming beef herd.
6. Technical Services Field Trial Report 93-14. 1993. Vision Weaning Weight Trials.
7. Veterinary Services Field Trial Report 93-15. 1993. Weight comparison at weaning in 5 beef herds comparing Vision (2 mL) to 5 mL 7-way administered at spring branding.
8. Veterinary Services Field Trial Report 96-5. 1996. Weaning weight comparison of calves vaccinated with Vision 8 vaccine or a 5 mL 8-way clostridial vaccine.
9. Pinkeye in cattle. Mississippi State University Extension Service. POD-02-14.
10. Clarke R. November 2014. The full cost of pinkeye in cattle. Canadian Cattlemen website. November 2014.
https://www.canadiancattlemen.ca/features/the-full-cost-of-pink-eye-in-cattle/. Accessed May 12, 2021.
11. Fulton RW. Bovine respiratory disease research (1983–2009). Cambridge University Press. Anim Health Res Rev. 2009;10(2):131–139.
12. Irsik M, Langemeier M, Schroeder T, Spire M, Roder JD. Estimating the Effects of Animal Health on the Performance of Feedlot Cattle. Bov Pract. 2006;40(2):65-74.
13. Comparison of endotoxin concentrations in BOVILIS® J-5 with those in three commercially available Gram-negative, lipopolysaccharide core-antigen vaccines, Merck Animal Health technical bulletin, 2020.
14. Brito LA, Singh M. Acceptable levels of endotoxin in vaccine formulations during preclinical research. J Pharm Sci. 2011;100:34-37.